Tecan Group AG's EBIT per Share for the
six
months ended in Dec. 2025 was $-12.19.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $-9.81.
During the past 12 months, the average EBIT per Share Growth Rate of Tecan Group AG was -35.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -31.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -18.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 0.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Tecan Group AG's EBIT per Share or its related term are showing as below:
TCHBF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -31 Med: 6.5 Max: 51
Current: -31
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Tecan Group AG was 51.00% per year. The lowest was -31.00% per year. And the median was 6.50% per year.
TCHBF's 3-Year EBIT Growth Rate is ranked worse than 90.7% of 688
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs TCHBF: -31.00
Tecan Group AG's EBIT for the
six
months ended in Dec. 2025 was $-154 Mil.
Tecan Group AG (OTCPK:TCHBF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Tecan Group AG EBIT per Share Related Terms
Tecan Group AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for Tecan Group AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-9.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tecan Group AG (TCHBF) has a EBIT per Share of $-9.81 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Tecan Group AG and its competitors. According to the industry distribution chart, Tecan Group AG ranks #624 out of 688 companies in the Medical Devices & Instruments industry, placing it in the top 90.7%.
Is Tecan Group AG's EBIT per Share too high?
Tecan Group AG's current EBIT per Share is $-9.81. Based on the distribution chart, Tecan Group AG ranks #624 out of 688 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tecan Group AG has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tecan Group AG ranks #624 out of 688 companies for EBIT per Share. This places Tecan Group AG in the lower half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Tecan Group AG and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tecan Group AG's current EBIT per Share is $-9.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (TCHBF) is currently considered Modestly Undervalued. The stock's GF Value™ is $302.91, compared to a current price of $225.65 — trading 25.5% below its estimated fair value. The current EBIT per Share is $-9.81. Tecan Group AG's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Tecan Group AG (TCHBF), the current EBIT per Share is $-9.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tecan Group AG (TCHBF) Overvalued in 2026?
Based on GuruFocus' analysis, Tecan Group AG stock appears to be undervalued.
The current stock price of $225.65 is trading 25.5% below its estimated GF Value™ of $302.91.
GuruFocus considers Tecan Group AG to be Modestly Undervalued.
Key valuation signals for TCHBF:
EBIT per Share: $-9.81
GF Value™: $302.91 vs. price of $225.65 (25.5% below fair value)
No single metric tells the full story. See the TCHBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
76GF Score
Get the complete analysis for TCHBF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TCHBF has been successfully added to your 
